scispace - formally typeset
C

Cyrus Cooper

Researcher at Southampton General Hospital

Publications -  1961
Citations -  248928

Cyrus Cooper is an academic researcher from Southampton General Hospital. The author has contributed to research in topics: Population & Osteoporosis. The author has an hindex of 204, co-authored 1869 publications receiving 206782 citations. Previous affiliations of Cyrus Cooper include University of Oxford & University of York.

Papers
More filters
Journal ArticleDOI

Epidemiology of fractures in the United Kingdom 1988-2012 : Variation with age, sex, geography, ethnicity and socioeconomic status

TL;DR: This study presents robust estimates of fracture incidence across the UK, which will aid decisions regarding allocation of healthcare provision to populations of greatest need and assist the implementation and design of strategies to reduce fracture incidence and its personal and financial impact on individuals and health services.
Journal ArticleDOI

Epidemiology of osteoporosis.

TL;DR: In this article, the epidemiology of osteoporosis, including the relationship between low bone mass and fracture, is reviewed, focusing on the sites where the majority of age-related fractures occur.
Journal ArticleDOI

Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

John N Newton, +92 more
- 05 Dec 2015 - 
TL;DR: In the Global Burden of Disease Study 2013 (GBDDS) as discussed by the authors, knowledge about health and its determinants has been integrated into a comparable framework to inform health policy.
Journal ArticleDOI

International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.

TL;DR: The IOF/IFCC recommends one bone formation marker and one bone resorption marker to be used as reference markers and measured by standardised assays in observational and intervention studies to enlarge the international experience of the application of markers to clinical medicine and to help resolve uncertainties over their clinical use.